ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
LAUSANNE, Switzerland, May 15, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive […]
ATHA Energy Provides Update on 2024 Exploration Program
BACKGROUND: ATHA Energy Corp. commenced its 2024 Exploration Program – the Company’s most significant exploration program to date and one […]
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GAITHERSBURG, Maryland and NESS ZIONA, Israel, May 15, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the […]
TSX News -
Bitfarms Reports First Quarter 2024 Results
– Revenue of $50 million, up 9% Q/Q and 67% Y/Y –– Gross mining margin of 59%, up from 52% […]
TSX News -
Boralex announces a substantial 62% increase in net earnings and continued disciplined development of highly promising projects
Highlights Financial results Higher EBITDA(A)1, operating income and net earnings than in Q1-2023 Increases mainly attributable to higher wind farm […]
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
Continued progress enrolling in its VMT-α-NET and VMT01 clinical trials Disclosed a new internally discovered molecule that targets fibroblast activation […]
Barrick’s Sustainability Strategy Delivers Real Value to Stakeholders
All amounts expressed in US dollars TORONTO, May 15, 2024 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) – Almost $12 […]
AYR Wellness Reports First Quarter 2024 Results
Q1 Revenue up 3% Q/Q to $118.0 Million, Excluding Discontinued Operations Q1 GAAP Loss from Operations Improved to $2.0 Million, […]
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
– No CRS or ICANS of any grade observed during the 28-day DLT observation window for either of the first […]
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) — Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and […]
